Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies.

[1]  Ozols Rf.  Outcome issues in ovarian cancer. , 1956 .

[2]  R. Ozols.  Outcome issues in ovarian cancer. , 1956, Oncology.

[3]  J. da Silva,et al.  Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. , 1985, Cancer research.

[4]  H. Wang,et al.  Identification of two factors required for transcription of the ovalbumin gene , 1986, Molecular and cellular biology.

[5]  B. O’Malley,et al.  COUP transcription factor is a member of the steroid receptor superfamily , 1989, Nature.

[6]  R. Ozols,et al.  Chemotherapy of ovarian cancer. , 1999, Seminars in oncology.

[7]  T. Kirchhausen,et al.  The beta 1 and beta 2 subunits of the AP complexes are the clathrin coat assembly components. , 1993, The EMBO journal.

[8]  Ken W. Y. Cho,et al.  Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. , 1997, Development.

[9]  Yixin Wang,et al.  POWER_SAGE: comparing statistical tests for SAGE experiments , 2000, Bioinform..

[10]  Rithy K. Roth,et al.  Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays , 2000, Nature Biotechnology.

[11]  B. Karlan,et al.  Chemotherapy in epithelial ovarian cancer. , 2002, Current women's health reports.

[12]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[13]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[14]  C. V. Jongeneel,et al.  Comprehensive sampling of gene expression in human cell lines with massively parallel signature sequencing , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Blake C Meyers,et al.  The use of MPSS for whole-genome transcriptional analysis in Arabidopsis. , 2004, Genome research.

[16]  M. Tsao,et al.  Expression of Chicken Ovalbumin Upstream Promoter-Transcription Factor II Enhances Invasiveness of Human Lung Carcinoma Cells , 2004, Cancer Research.

[17]  J. Massagué,et al.  Epithelial-Mesenchymal Transitions Twist in Development and Metastasis , 2004, Cell.

[18]  Rodrigo D. Drummond,et al.  ISER: selection of differentially expressed genes from DNA array data by non-linear data transformations and local fitting , 2005, Bioinform..

[19]  John N. Weinstein,et al.  High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID) , 2005, BMC Bioinformatics.

[20]  R. Ozols.  Treatment goals in ovarian cancer , 2005, International Journal of Gynecologic Cancer.

[21]  P. Shannon,et al.  Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: a systems approach to disease. , 2005, Cancer research.

[22]  L. Ellis,et al.  Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines , 2006, Clinical Cancer Research.

[23]  Biaoyang Lin,et al.  Proteins Associated with Cisplatin Resistance in Ovarian Cancer Cells Identified by Quantitative Proteomic Technology and Integrated with mRNA Expression Levels*S , 2006, Molecular & Cellular Proteomics.

[24]  M. Nachtigal,et al.  BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. , 2007, Carcinogenesis.

[25]  D. Ward,et al.  Macrophage migration inhibitory factor expression in ovarian cancer. , 2007, American journal of obstetrics and gynecology.

[26]  T. Hagemann,et al.  Ovarian cancer cell–derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis , 2007, Molecular Cancer Therapeutics.

[27]  Bin Liu,et al.  Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together , 2006, Nucleic Acids Res..

[28]  J. Becker,et al.  Macrophage Migration Inhibitory Factor Contributes to the Immune Escape of Ovarian Cancer by Down-Regulating NKG2D1 , 2008, The Journal of Immunology.

[29]  L. Hood,et al.  Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and p53 binding protein 1 are important for chemotherapy response in ovarian cancers. , 2009, Omics : a journal of integrative biology.

[30]  D. Clarke‐Pearson,et al.  Screening for Ovarian Cancer , 2009 .

[31]  Jing Gao,et al.  Integrating and annotating the interactome using the MiMI plugin for cytoscape , 2009, Bioinform..

[32]  Siu-Ming Yiu,et al.  SOAP2: an improved ultrafast tool for short read alignment , 2009, Bioinform..